Online Media Kit


January 26, 2021 | World Health Organization

WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »


November 30, 2020 | New York Times

Berry-Flavored H.I.V. Medication Is Ready for Babies

The World Health Organization approved the dapivirine ring, a vaginal insert that has proved effective in women who use it consistently. Finding prevention methods that women can use discreetly has... More »


July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »


July 24, 2020 | Times LIVE (South Africa)

Vaginal ring gives women more options for HIV prevention

Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »

Media Highlights

July 27, 2020 | FDAnews

EMA Committee Recommends Dapivirine Vaginal Ring

Placed in the vagina, the silicone ring slowly releases the antiretroviral medicine dapivirine for 28 days. More »

July 27, 2020 | European Pharmaceutical Review

EMA recommends 11 new medicines for approval following July meeting

The CHMP adopted a positive opinion for Dapivirine Vaginal Ring (dapivirine), used to reduce the risk of infection with HIV-1. More »

July 27, 2020 | Daily Nation (Kenya)

Agency approves monthly vaginal ring as new HIV prevention method

A silicone vaginal ring containing antiretroviral drug dapivirine has received an agency's approval as a new HIV prevention method for women. More »

July 26, 2020 | The Sunday News (Zimbabwe)

Ring to reduce HIV by 45 percent

The dapivirine vaginal ring has been under study as an HIV preventative tool for 16 years and received a nod from the EMA. More »

July 26, 2020 | SABC News (South Africa)

Regulatory process for the roll-out of the antiretroviral ring needs to start in SA: Health Department

The National Health Department says it will start with the regulatory processes in preparation for the roll-out of the dapivirine vaginal ring in South Africa to prevent the transmission of HIV. More »